Form 4: Centessa Pharmaceuticals Executive Gregory Weinhoff Reports Share Disposal for Tax Obligations
SEC Form 4
Gregory Weinhoff, Chief Business Officer of Centessa Pharmaceuticals, disposed of shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- On September 30, 2024, Gregory M. Weinhoff, Chief Business Officer of Centessa Pharmaceuticals plc, disposed of 11,742 ordinary shares to cover tax withholding obligations.
- The shares were disposed of at a price of $15.79 per share.
- Following the transaction, Weinhoff directly owns 195,008 ordinary shares of Centessa Pharmaceuticals plc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock disposal for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment with company performance.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares for tax obligations and does not indicate a change in the executive's overall confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of the share disposal transaction. |
| 10/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.